1. Wang Z, Zeng Z, Gao F, Gui Z, Du J, Shen N, Shang Y, Yang Z, Shang L, Wei R, Ma W, Wang C. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression. BMC Med Genomics. 2023，20;16(1):30.

2. Chen Y, Du X, Gao Y, Wu H, Zhao H, Su Y. Methylthioadenosine Phosphorylase and Breast Cancer 1 Protein-Associated Protein 1 as Biomarkers for the Peritoneal Mesothelioma. Cancer Control. 2023;30: 1-9. doi:10.1177/10732748231220805

3. Du X, Li X, Zhang B, Hao Z, Gao Y, Jiang X, Yang Z, Chen Y. The clinicopathological significance of TOP2A expression in malignant peritoneal mesothelioma. Ann Diagn Pathol. 2023;65:152155.

4. Xie R, Wang W, Thomas AM, Li S, Qin HM?. Maxillary clear cell odontogenic carcinoma with EWSR1-ATF1 fusion gene mimicking sclerosing odontogenic carcinoma: A case report and literature review. Pathol Res Pract. 2023 Jan; 241:154257.

5. 石峰,高穎,趙洪禹,等. 原發(fā)CD5陽性彌漫大B細(xì)胞淋巴瘤18例臨床病理特征[J]. 臨床與實驗病理學(xué)雜志,2023,39(2):162-168. 

6. 杜雪梅,李鑫寶,孟巍,等. 惡性腹膜間皮瘤100例臨床病理特征及預(yù)后分析[J]. 中國腫瘤臨床,2023,50(8):403-410.

7. 張爽,石峰,昌紅.胃腸道杯狀細(xì)胞腺癌臨床病理分析[J].腫瘤, 2022, 42 (12): 797-805.  

8. 杜雪梅, 高穎, 蘇延冬, 等. STK11基因突變的原發(fā)性腹膜上皮樣間皮瘤1例[J]. 中華病理學(xué)雜志, 2023, 52(7): 745-747.

9. 崔力方,陳奕至,余春開,等. 淺談乳腺浸潤性導(dǎo)管癌標(biāo)準(zhǔn)化病理報告模板的建立和應(yīng)用[J]. 診斷病理學(xué)雜志,2022,29(2):190-191. DOI:10.3969/j.issn.1007-8096.2022.02.028.

10. 杜雪梅,魏亞萍,高穎,等. 上皮樣型惡性腹膜間皮瘤透明細(xì)胞亞型2例[J]. 中華病理學(xué)雜志,2022,51(1):68-70. DOI:10.3760/cma.j.cn112151-20210722-00523.

11. Yue Chen, Haoyue Hu, Xianglei Yuan, Xue Fan, Chengda Zhang. Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma. Front Immunol. 2022, 13: 896752.

12. Yue Chen, Haoyue Hu, Songtao Tan, Qionglan Dong, Xue Fan, Yi Wang, Huan Zhang, Jun He. The role of neutrophil extracellular traps in cancer progression, metastasis and therapy. Exp Hematol Oncol. 2022, 11(1): 99.

13. Haoyue Hu, Yue Chen, Songtao Tan, Silin Wu, Yan Huang, Shengya Fu, Feng Luo, Jun He. The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment. Front Immunol. 2022, 13: 802846.

14. Yue Chen, YaPing Wei, Hong Chang, ChunKai Yu. Case report and literature review: Rare male aggressive angiomyxoma of the scrotum. Front Surg. 2022, 9: 955655.

15. 陳悅, 昌紅, 石峰. CD5陽性濾泡性淋巴瘤1例. 臨床與實驗病理學(xué)雜志, 2022, 38(9):2.

16. Li H, Liu J, Fan N, Wang H, Thomas AM, Yan Q, Li S, Qin H. Nav1.6 promotes the progression of human follicular thyroid carcinoma cells via JAK-STAT signaling pathway. Pathol Res Pract. 2022 Aug;236:153984. doi:10.1016/j.prp.2022.153984. Epub 2022 Jun 17. PMID: 35753135.

17. Sun Pingping, Ma Ru, Liu Gang, Wang Lingling, Chang Hong, Li    Yan*(Corresponding Author). Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases. Ann Transl Med. 2021, 9(7):574

18. Sun PingPing, Du XueMei, Gao Ying, Zhao HongYu, Wang LingLing, Zhang Ying, Li Yan*(Corresponding Author). Clinicopathologic features of retroperitoneal malignant solitary fibrous tumors. Critical Reviews in Eukaryotic Gene Expression. 2021, 31(4):21–33

19. Wang LingLing, Ji Zhong-He, Gao Ying, Chang Hong, Sun PingPing， Li Yan*(Corresponding Author). Clinicopathological features of desmoplastic small round cell tumors: clinical series and literature review. World Journal of Surgical Oncology (2021) 19:193

20. Yan Fengcai, Shi Feng, Li Xinbao, Chang Hong, Jin Mulan, Li Yan*(Corresponding Author). Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin. Journal of International Medical Research, 2021, 49(6):1–11

21. Du Xuemei , Cao D, Yan Fengcai, Gao Ying, Chang Hong , Wei Bojun *(Corresponding Author). Clinicopathological characteristics of mucinous variant of anaplasiatic thyroid carcinoma

22.  Xue-Mei Du , Ya-Ping Wei , Ying Gao 1, Zhao Li 1, Jian-Mei Zhang 2, Hong Chang 1,Li Tan*(Corresponding Author). Clinicopathological characteristics of primary peritoneal epithelioid mesothelioma of clear cell type: A case report,medicine,2021, 100(12):e25264

23. Yan Fengcai, Lin Yulin, Zhou Quan, Chang Hong, Li Yan*(Corresponding Author). Pathological prognostic factors of pseudomyxoma peritonei:comprehensive clinicopathological analysis of 155 cases. Human pathology,2020,97:9-18.IF：2.735

24. Yan Fengcai,Shi Feng,Li Xinbao, Yu Chunkai,Lin Yulin,Li Yan,Jin Mulan*(Corresponding Author).Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries.Cancer Management and Research,2020,12:7569–7578.IF:2.886

25.  Shi Feng, Xiao Shuo, Miller Kaeli B, Zhao Yanjie, Li Yuchen, Gao Ying, Chang Hong,Song Qingkun*(Corresponding Author)，Qu Chenxu. Interactive effects of PD-L1 expression in tumor and immune cells on prognosis of esophageal aquamous cell carcinoma: a one-center retrospective cohort study. OncoTargets and Therapy. 2020,13:565-6572. IF：3.046

26. Song Qingkun, Shi Feng*(Corresponding Author), Xiao Shuo, Li Yuchen, Zhao Yanjie, Chang Hong*(Corresponding Author). The integration of proportion and cell counts of stromal, not intratumoral, PD-1+ tumor-infiltrating lymphocytes has prognostic significance in esophageal squamous cell carcinoma. Dis Esophagus. 2020, 12:doaa035.1.IF:2.386

27. 孫萍萍,趙洪禹,王玲玲,張穎,杜雪梅,閆風(fēng)彩,李雁*（通訊作者）.腹膜后惡性孤立性纖維性腫瘤的臨床病理分析.臨床腫瘤學(xué)雜志,2020,47(2):72-76.

28. 王玲玲,馬茹,昌紅,高穎,李雁*（通訊作者）.腎上腺嗜鉻細(xì)胞瘤的臨床病理特征分析.臨床腫瘤學(xué)雜志,2020,25(3):257-260.

29. 王玲玲,姬忠賀,高穎,昌紅,周全,孫萍萍,張穎,李雁*（通訊作者）.促結(jié)締組織增生性小圓細(xì)胞腫瘤的臨床病理特征分析.中國腫瘤臨床,2020,47(2):72-76.

30. 孫萍萍,余春開，張博，馬茹，杜雪梅*（通訊作者）. 胃混合性腺神經(jīng)內(nèi)分泌癌的臨床病理分析. 診斷病理學(xué)雜志,2020,3:167-171.

31. 閆風(fēng)彩,周全,昌紅,李雁*（通訊作者）.病理科輪轉(zhuǎn)醫(yī)師規(guī)范化培訓(xùn)的教學(xué)實踐.診斷病理學(xué).2020,9(25):688-689.

32. Lifang Cui, Xinmin Zhang, Jixin Zhang, Hong Chang* (corresponding author), Hongyu Zhao, Congling Qu, Jianying Zhang, Ying Gao. Hepatoid adenocarcinoma of colon: a case report and literature review. Int J Clin Exp Med 2019;12(4):4459-4463.

33. Wang LL, Cui LF, Gao Y, Jiang ZC*(corresponding author). Clinicopathologic features of Stewart-Treves syndrome. Int J Clin Exp Pathol. 2019, 12(3): 680-688.

34. 閆風(fēng)彩，李鑫寶，林育林，余春開，周全，李雁*（通訊作者）. 卵巢來源腹膜假黏液瘤臨床病理分析[J].中國腫瘤臨床2019,46(17)887-890.

35. 崔力方,王大業(yè)*（通訊作者）.淺談醫(yī)學(xué)本科病理實驗帶教過程中的教學(xué)模式[J].診斷病理學(xué)雜志,2019,26(09):632-633.

36. 杜雪梅,李鑫寶,馬玲,高穎,孫萍萍,李雁*（通訊作者）.腹膜惡性間皮瘤中腫瘤浸潤淋巴細(xì)胞和Ki-67表達(dá)與臨床病理特征及預(yù)后的關(guān)系[J].臨床與實驗病理學(xué)雜志,2019,(08):920-923+928.

37. 閆風(fēng)彩, 林育林, 趙洪禹, 周全，昌紅，李雁*（通訊作者）.腹膜假黏液瘤155例病理預(yù)后因素分析[J].中華病理學(xué)雜志,2019,48(7):543-549.

38. 余春開,宋志剛*（通訊作者）.膀胱淀粉樣變性的臨床病理特點、診斷及預(yù)后分析[J].診斷病理學(xué)雜志,2019(08):499-502.

39. 崔力方, 張繼新,李曌，高穎，魯濤，趙洪禹，鐘定榮*（通訊作者）. 結(jié)外濾泡樹突細(xì)胞肉瘤的臨床病理學(xué)特點. 中華腫瘤雜志, 2019,41(3):218-221

40. Shi F, Chang H*(corresponding author), Zhou Q, Zhao YJ, Wu GJ, Song QK*(corresponding author). Distribution of CD4+ and CD8+ exhausted tumor-infiltrating lymphocytes in molecular subtypes of Chinese breast cancer patients. Onco Targets Ther. 2018; 11: 6139-6145.

41. Yan FC, Zhou Q* (corresponding author), Gao Y, et al. Isolated Langerhans cell histiocytosis of the stomach:a case report and literature review. Int J Clin Exp Pathol 2018;11(12):5962-5968.

42. Wang LL, Jiang ZC*(corresponding author), Zhang CY , Gao Y. Malignant glomus tumor of the ileum mimicking GIST with distant metastasis without BRAF V600E mutation. Int J Clin Exp Pathol. 2018;11(10):5117-5125.

43. Du XM, Gao Y, Sun PP, Chen YZ, Chang H, Wei BJ *(corresponding author).CD163+/CD68+tumor-associated macrophages in angiosarcoma with lymphedema. Int J Clin Exp Pathol. 2018;11(4):2106-2111.

44. Du XM, Gao Y, Zhao HY, Li B, Xue WM, Wang DY*(corresponding author). Clinicopathological analysis of epithelioid inflammatory myofibroblastic sarcoma. Oncol Lett. 2018; 15(6): 9317-9326.

45. Du XM, Wang DY, Li B, Chang H, Shen DH*(corresponding author). Clinicopathological features of primary myoepithelial carcinoma inside oblique eminence of cuboid bone: a case report. Int J Clin Exp Med. 2018; 11(6): 6327-6331.

46. 崔力方, 張繼新, 昌紅, 趙宏禹, 李曌, 曲叢玲, 鐘定榮*(通訊作者). 伴上皮成分惡變的乳腺葉狀腫瘤5例臨床病理分析[J]. 診斷病理學(xué)雜志. 2018; 25(1): 12-16.

47. 余春開, 宋志剛, 陳敬, 石懷銀*(通訊作者). 顳骨中心性巨細(xì)胞病變15例臨床病理分析[J]. 診斷病理學(xué)雜志. 2018(1): 25-27.

48. 余春開, 魏海亮, 昌紅, 宋志剛*(通訊作者). 硬皮病繼發(fā)特發(fā)性間質(zhì)性肺炎合并肺癌1例[J]. 診斷病理學(xué)雜志. 2018; 25(1): 76-77.

49. 石峰, 趙琳*(通訊作者), 宋清坤, 周全. 病理住院醫(yī)師規(guī)范化培訓(xùn)的教學(xué)實踐[J]. 中國病案. 2018; 19(5): 91-93.

50. 張穎, 孫志鵬, 余春開, 王玲玲, 趙洪禹, 周全*(通訊作者). 胃癌患者癌組織中PDK-1蛋白表達(dá)水平及其臨床意義[J]. 中國煤炭工業(yè)醫(yī)學(xué)雜志. 2018; 21(3): 298-303.

51. 余春開, 周全*(通訊作者). 病理科進(jìn)修醫(yī)師規(guī)范化培訓(xùn)的實踐與體會[J]. 診斷病理學(xué)雜志. 2018; 25(6): 480-481.

52. 周全, 石峰, 趙洪禹, 李雁, 宋清坤*(通訊作者). 腹膜黏液性腫瘤的臨床病理分析[J]. 中華病理學(xué)雜志. 2018; 47(3): 192-195.

53. 周全, 肖琳, 徐景美, 徐冰, Karen Wu, 劉晶, 盧艷, 褚利群*(通訊作者). MCP-1及其受體在wAMD小鼠模型視網(wǎng)膜中的表達(dá)及作用機制[J]. 臨床與實驗病理學(xué)雜志. 2018; 34(1): 32-36.

54. 崔力方, 昌紅, 趙洪禹, 曲叢玲, 高穎, 劉紅剛*(通訊作者). 喉基底樣鱗狀細(xì)胞癌中人乳頭狀瘤病毒及細(xì)胞周期相關(guān)蛋白的表達(dá)[J]. 中華病理學(xué)雜志. 2018; 47(9): 682-686.

55. 王玲玲, 姜忠彩*(通訊作者), 張穎, 沈冰. 6例胸腺瘤轉(zhuǎn)移至肺組織的臨床病理觀察[J]. 臨床腫瘤學(xué)雜志. 2018; 23(8): 743-746.

56. 杜雪梅，李鑫寶，于洋，孫萍萍，高穎，昌紅，李雁*(通訊作者). 惡性間皮瘤中PD-1和PD-L1的表達(dá)及意義.臨床與實驗病理學(xué)雜志. 2018;34（12）

57. 張穎, 周全*(通訊作者), 王玲玲, 等. 伴間葉分化的乳腺化生性癌7例臨床病理分析. 腫瘤學(xué)雜志. 2018, 24(11): 1122-1125.

58. 王玲玲，周全，崔力方，石峰，高穎，孟艷* (通訊作者).Stewart-Treves綜合征13例臨床病理分析[J].診斷病理學(xué)雜志,2018,25(11):742-745.